Glenmark gets euro 25mn from Merck

Glenmark Pharmaceuticals today said it had received euro 25 million from German pharma major Merck as milestone payment for an out licensing deal.

This is part of a euro 190 million deal between the two companies to develop Glenmark's diabetes drug.